Puma Biotech (PBYI) Reports Q4 Loss of $1.23/Share

Puma Biotech (NYSE: PBYI) reported Q4 EPS of ($1.23), versus ($1.03) reported last year.

For earnings history and earnings-related data on Puma Biotech (PBYI) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Bernstein SocGen Group Upgrades Engie SA (ENGI:FP) (ENGIY) to Outperform
• Catalyst Metals Ltd (CYL:AU) PT Lowered to AUD9.25 at UBS